Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Doctor Compares Wegovy Injections to New Weight Loss Pill - Featured image
GLP-1 Medications

Doctor Compares Wegovy Injections to New Weight Loss Pill

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·January 15, 2026·2 min read

On this page

  • Dr. Drew Payne on Key Differences
  • Consistent Weight Loss Results
  • Significant Cost Savings
  • Prescription Requirements and Switching

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

The new FDA-approved Wegovy pill offers the same weight loss benefits as injections but in a daily oral dose. Dr. Drew Payne explains why higher doses are needed due to GI absorption and how both achieve 15% average weight loss. Costs drop significantly, making treatment more affordable.

Share

On this page

  • Dr. Drew Payne on Key Differences
  • Consistent Weight Loss Results
  • Significant Cost Savings
  • Prescription Requirements and Switching

Weight loss medication Wegovy is now available in pill form, delivering the same active ingredient, semaglutide, as the weekly injections but as a daily oral dose. This option could improve accessibility and affordability for obesity treatment.

Dr. Drew Payne on Key Differences

The FDA-approved pill contains the same medicine as Wegovy injections, but it requires higher dosages because absorption in the gastrointestinal tract is lower, explained Dr. Drew Payne, D.O., an internist at Texas Tech Health Sciences Center specializing in obesity.

"The ingredient in the pill or the active medicine in the pill is the same as the injection," Payne said. "The only real kind of difference is the medicine isn't absorbed as well in the GI tract so the dosage is quite a bit higher."

Consistent Weight Loss Results

At maximum doses, both the pill and injection versions help patients lose about 15% of their body weight on average, according to Payne. Side effects are also similar between the two forms.

Patient Pam Simpson lost 55 pounds using the injection and called it "one of the best decisions I've ever made." Diane Harlan lost 105 pounds, reducing her blood pressure medication needs, and said, "I think it's a miracle... It was the easiest thing I've ever done."

Significant Cost Savings

The pill version costs much less than injections. Wegovy pricing starts at $149 per month, with the highest doses under $400, compared to over $1,000 monthly for some injection users.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

"The cost will be less because it's less to manufacture," Payne said. "You don't have the auto-injector cost built into it."

Prescription Requirements and Switching

A prescription is still required for the pill. Patients can order it directly from the manufacturer's website with a physician's approval, and local pharmacies will soon stock it.

  • Approved for patients age 12 and older
  • Current injection users can switch to the pill
  • Apps like Shotlee help track daily GLP-1 doses for consistency

"You can switch from an injection to a pill," Payne said. Simpson prefers sticking with injections: "I don't like the idea of taking a pill every day."

The drug does not work for everyone, and rare serious side effects are possible, necessitating doctor monitoring via prescription.

Source Information

Originally published by https://www.kcbd.com.Read the original article →

Read next

Keep exploring

More on Wegovy

Articles covering Wegovy dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Wegovy

All Wegovy articles →
Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read

More in GLP-1 Medications

5 Things to Know Before Switching to Oral GLP-1 Pills
GLP-1 Medications

5 Things to Know Before Switching to Oral GLP-1 Pills

Oral GLP-1 medications offer a convenient alternative to weekly injections for weight loss. Discover the main differences in absorption, dosing, and routine. Follow these 5 tips to ensure a successful switch without losing progress.

2 min read
Novo Nordisk Pushes Consumer-Friendly Wegovy Pill
GLP-1 Medications

Novo Nordisk Pushes Consumer-Friendly Wegovy Pill

Novo Nordisk ramps up direct-to-consumer access to its new daily Wegovy pill through NovoCare's redesign and telehealth ties. Berenberg analysts see rising demand from consumers seeking speed and privacy over traditional clinics. This shift makes GLP-1 weight loss treatment feel like online shopping.

1 min read
Novo's Wegovy Oral Pill Shows Strong Early US Momentum vs Lilly
GLP-1 Medications

Novo's Wegovy Oral Pill Shows Strong Early US Momentum vs Lilly

Novo Nordisk's new oral Wegovy pill achieved 3,071 retail prescriptions in its first four days in the US. This strong start signals competition with Eli Lilly's offerings. Analysts predict up to $1 billion in 2024 sales if momentum continues.

1 min read
Share this article
  1. Home
  2. Blog
  3. Doctor Compares Wegovy Injections to New Weight Loss Pill
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community